Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial
Clinical trial NCT07616531 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07616531
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2029-02-28
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.